We are live on ! Find out more
CRL icon

Charles River Laboratories

664 hedge funds and large institutions have $10.8B invested in Charles River Laboratories in 2024 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 266 increasing their positions, 235 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 266 | Existing positions reduced: 235

0.06% less ownership

Funds ownership: 101.79%101.73% (-0.06%)

6% less first-time investments, than exits

New positions opened: 74 | Existing positions closed: 79

2% less funds holding

Funds holding: 676664 (-12)

15% less call options, than puts

Call options by funds: $54.2M | Put options by funds: $63.4M

23% less capital invested

Capital invested by funds: $14.1B → $10.8B (-$3.32B)

47% less funds holding in top 10

Funds holding in top 10: 158 (-7)

Holders
664
Holders Change
-12
Holders Change %
-1.78%
% of All Funds
9.59%
Holding in Top 10
8
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-46.67%
% of All Funds
0.12%
New
74
Increased
266
Reduced
235
Closed
79
Calls
$54.2M
Puts
$63.4M
Net Calls
-$9.19M
Net Calls Change
+$37.2M
Name Holding Trade Value Shares
Change
Change in
Stake
AIG
676
American International Group
New York
-$3.63M -13,410 Closed
LIP
677
Lighthouse Investment Partners
Florida
-$3.55M -13,116 Closed
TPSF
678
Texas Permanent School Fund
Texas
-$2.87M -10,602 Closed
SPS
679
Susquehanna Portfolio Strategies
Pennsylvania
-$2.87M -10,600 Closed
JFG
680
Jefferies Financial Group
New York
-$2.36M -8,720 Closed
MA
681
Montag & Associates
Georgia
-$2.23M -8,221 Closed
HF
682
HRT Financial
New York
-$1.31M -4,856 Closed
LWAM
683
Legacy Wealth Asset Management
Minnesota
-$931K -3,437 Closed
BCM
684
Brasada Capital Management
Texas
-$813K -3,000 Closed
Simplex Trading
685
Simplex Trading
Illinois
-$673K -2,970 Closed
FA
686
FDx Advisors
Illinois
-$710K -2,621 Closed
DFCM
687
Dark Forest Capital Management
Puerto Rico
-$652K -2,405 Closed
MLICM
688
Metropolitan Life Insurance Company (MetLife)
New York
-$561K -2,069 Closed
OC
689
Oppenheimer & Co
New York
-$473K -1,745 Closed
BTWM
690
Baker Tilly Wealth Management
Wisconsin
-$459K -1,693 Closed
SCA
691
Sandy Cove Advisors
Massachusetts
-$417K -1,538 Closed
FMC
692
First Merchants Corp
Indiana
-$404K -1,491 Closed
AC
693
Avestar Capital
New York
-$349K -1,287 Closed
XT
694
XTX Topco
Cayman Islands
-$330K -1,217 Closed
KIA
695
KCM Investment Advisors
California
-$318K -1,172 Closed
AC
696
ASB Consultores
Florida
-$313K -1,156 Closed
AWCI
697
Alpine Woods Capital Investors
New York
-$262K -1,145 Closed
BA
698
Bridgewater Associates
Connecticut
-$298K -1,100 Closed
EFG
699
Ethos Financial Group
Pennsylvania
-$296K -1,093 Closed
QCM
700
QRG Capital Management
Illinois
-$284K -1,047 Closed

CRL Hedge Fund Activity: Q2 2024 in Review

664 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2024, worth a combined $10.8B — down 23% from $14.1B a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of CRL and 74 opened new positions — a net loss of 5 holders — while 235 trimmed existing stakes and 266 added.

The largest buyer was Southpoint Capital Advisors, adding an estimated $102M. The largest seller was T. Rowe Price Associates, cutting an estimated $154M.

  • 664 institutional investors held Charles River Laboratories (CRL) as of Q2 2024, down from 676 in Q1 2024.
  • Funds reported $10.8B of Charles River Laboratories stock for Q2 2024, down 23% quarter-over-quarter.
  • 74 funds opened new Charles River Laboratories positions in Q2 2024 and 79 closed out, a net change of -5 holders.
  • The largest Charles River Laboratories buyer in Q2 2024 was Southpoint Capital Advisors, an estimated $102M added.
  • The largest Charles River Laboratories seller in Q2 2024 was T. Rowe Price Associates, an estimated $154M sold.

Based on aggregated 13F filings for Q2 2024.